Junfa Li Selected Research

Junfa Li Research Topics

Disease

18	Ischemic Stroke 10/2022 - 10/2013
17	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022 - 01/2012
16	Infarction (Infarctions) 01/2020 - 04/2011
14	Wounds and Injuries (Trauma) 01/2020 - 04/2011
11	Pain (Aches) 01/2022 - 07/2007
9	Ischemia 08/2020 - 12/2007
9	Hypoxia (Hypoxemia) 12/2019 - 08/2005
7	Stroke (Strokes) 10/2022 - 06/2010
7	Postoperative Pain 01/2018 - 10/2009
6	Brain Ischemia (Cerebral Ischemia) 12/2019 - 04/2011
5	Hyperalgesia 10/2020 - 10/2009
3	Inflammation (Inflammations) 04/2021 - 08/2011
3	Edema (Dropsy) 03/2013 - 04/2011
2	Demyelinating Diseases (Demyelinating Disease) 10/2022 - 01/2021
2	Necrosis 04/2021 - 11/2015
2	Morphine Dependence 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 01/2018
2	Brain Injuries (Brain Injury) 01/2017 - 05/2011
2	Neoplasms (Cancer) 01/2017 - 07/2014
2	Body Weight (Weight, Body) 01/2017 - 12/2006
2	Glioma (Gliomas) 01/2017 - 03/2014
2	Ganglion Cysts (Ganglion) 01/2016 - 12/2007
2	Dehydration (Water Stress) 01/2007 - 08/2006
1	Pathologic Processes 04/2021
1	Chronic Pain 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Carcinogenesis 01/2020

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2005
17	Oxygen (Dioxygen)IBA 10/2022 - 02/2012
16	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2013
7	Protein Kinase CIBA 01/2018 - 06/2006
5	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 01/2010
5	Messenger RNA (mRNA)IBA 10/2020 - 01/2013
5	Remifentanil (Ultiva)FDA Link 01/2018 - 10/2009
5	Protein Isoforms (Isoforms)IBA 01/2018 - 06/2006
4	InterleukinsIBA 04/2021 - 06/2017
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2017
4	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 10/2009
4	Propofol (Diprivan)FDA LinkGeneric 01/2017 - 10/2009
4	MicroRNAs (MicroRNA)IBA 09/2016 - 03/2012
4	p38 Mitogen-Activated Protein KinasesIBA 03/2013 - 08/2007
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2010
3	salicylhydroxamic acid (SHAM)IBA 10/2020 - 08/2013
3	Caspase 3 (Caspase-3)IBA 01/2020 - 11/2015
3	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2017
3	Protein Kinases (Protein Kinase)IBA 05/2016 - 04/2007
3	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 05/2011 - 01/2011
2	9- (benzoyloxy)- 2- (3- furanyl)dodecahydro- 6a,10b- dimethyl- 4,10- dioxo- 2H- naphtho(2,1- c)pyran- 7- carboxylic acid methyl esterIBA 04/2021 - 01/2017
2	Caveolin 1IBA 01/2021 - 10/2020
2	Ketamine FDA LinkGeneric 10/2020 - 01/2012
2	Monoclonal AntibodiesIBA 01/2020 - 02/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 01/2017
2	CytokinesIBA 01/2019 - 08/2011
2	Therapeutic UsesIBA 01/2019 - 01/2019
2	AMPA Receptors (AMPA Receptor)IBA 01/2018 - 01/2011
2	PropionatesIBA 01/2018 - 01/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 01/2018
2	triphenyltetrazoliumIBA 01/2018 - 08/2013
2	Synapsins (Synapsin I)IBA 01/2018 - 05/2011
2	GalaninIBA 02/2017 - 01/2017
2	Beclin-1IBA 12/2016 - 07/2014
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2016 - 04/2013
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2016 - 04/2013
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2016 - 08/2013
2	Retinaldehyde (Retinal)IBA 01/2016 - 12/2007
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2015 - 10/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2007 - 07/2007
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2007 - 08/2006
1	NeuroliginsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	EnzymesIBA 04/2021
1	ImmunosorbentsIBA 04/2021
1	NLR ProteinsIBA 04/2021
1	Activin Receptors (Activin Receptor)IBA 01/2021
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2021
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2021
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 01/2021
1	activin AIBA 01/2021
1	Kainic Acid Receptors (Kainate Receptor)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Freund's AdjuvantIBA 10/2020
1	Antidepressive Agents (Antidepressants)IBA 10/2020
1	Sirtuin 1IBA 08/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 08/2020
1	Biological ProductsIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Complement Factor B (Factor B)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2020
1	Caspase 12IBA 01/2020
1	Conditioned Culture MediaIBA 12/2019
1	Neuroprotective AgentsIBA 12/2019

Therapy/Procedure

3	Therapeutics 10/2022 - 04/2011
2	Anesthesia 01/2016 - 10/2009